Morphometric changes in the reward system of Parkinson’s disease patients with impulse control disorders

Journal of Neurology

Volumn 262, Issue 12, 2015, Pages 2653-2661

  Pellicano, Clelia ^a,b   Niccolini, Flavia ^a,c   Wu, Kit ^a   O’Sullivan, Sean S ^d   Lawrence, Andrew D ^e   Lees, Andrew J ^d   Piccini, Paola ^a   Politis, Marios ^a,c  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Cortical thickness; Impulse control disorders; MRI; Parkinson s disease

Indexed keywords

ADULT; AGED; AMYGDALOID NUCLEUS; ANTERIOR CINGULATE; ARTICLE; AUTOMATION; BASAL GANGLION; BRAIN ATROPHY; BRAIN SIZE; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICAL THICKNESS (BRAIN); FEMALE; HIPPOCAMPUS; HUMAN; IMPULSE CONTROL DISORDER; LIMBIC CORTEX; MALE; MIDDLE AGED; MORPHOMETRICS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEUS ACCUMBENS; PARKINSON DISEASE; PRIORITY JOURNAL; REWARD; SUBCORTEX; AMYGDALA; COMPLICATION; CORPUS STRIATUM; DISRUPTIVE, IMPULSE CONTROL, AND CONDUCT DISORDERS; LIMBIC SYSTEM; PATHOLOGY; PREFRONTAL CORTEX;

ADULT; AGED; AMYGDALA; CAUDATE NUCLEUS; CORPUS STRIATUM; DISRUPTIVE, IMPULSE CONTROL, AND CONDUCT DISORDERS; FEMALE; HIPPOCAMPUS; HUMANS; LIMBIC SYSTEM; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NUCLEUS ACCUMBENS; PARKINSON DISEASE; PREFRONTAL CORTEX; REWARD;

EID: 84947870738     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-015-7892-3     Document Type: Article

References (46)

1. Wu K, Politis M, Piccini P (2009) Parkinson disease and impulse control disorders: a review of clinical features, pathophysiology and management. Postgrad Med J 85:590–596
2. Weintraub D, Koester J, Potenza MN et al (2010) Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 67:589–595
3. Leeman RF, Billingsley BE, Potenza MN (2012) Impulse control disorders in Parkinson’s disease: background and update on prevention and management. Neurodegener Dis Manag 2:389–400
4. O’Sullivan SS, Wu K, Politis M et al (2011) Cue-induced striatal dopamine release in Parkinson’s disease-associated impulsive–compulsive behaviours. Brain 134:969–978
5. Steeves TD, Miyasaki J, Zurowski M et al (2009) Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study. Brain 132:1376–1385
6. Cilia R, Cho SS, van Eimeren T et al (2011) Pathological gambling in patients with Parkinson’s disease is associated with fronto-striatal disconnection: a path modeling analysis. Mov Disord 26:225–233
7. vanEimeren T, Pellecchia G, Cilia R et al (2010) Drug-induced deactivation of inhibitory networks predicts pathological gambling in PD. Neurology 75:1711–1716
8. Voon V, Pessiglione M, Brezing C et al (2010) Mechanisms underlying dopamine-mediated reward bias in compulsive behaviors. Neuron 65:135–142
9. Politis M, Loane C, Wu K et al (2013) Neural response to visual sexual cues in dopamine treatment-linked hypersexuality in Parkinson’s disease. Brain 136:400–411
10. Caprioli D, Sawiak SJ, Merlo E et al (2014) Gamma aminobutyric acidergic and neuronal structural markers in the nucleus accumbens core underlie trait-like impulsive behavior. Biol Psychiatry 75:115–123
11. Wheeler AL, Lerch JP, Chakravarty MM et al (2013) Adolescent cocaine exposure causes enduring macroscale changes in mouse brain structure. J Neurosci 33:1797–1803a
12. Cerasa A, Salsone M, Nigro S et al (2014) Cortical volume and folding abnormalities in Parkinson’s disease patients with pathological gambling. Parkinsonism Relat Disord. pii: S1353-8020(14)00323-X [Epub ahead of print]
13. Biundo R, Weis L, Facchini S et al (2015) Patterns of cortical thickness associated with impulse control disorders in Parkinson’s disease. Mov Disord. doi:10.1002/mds.26154[Epub ahead of print]
14. Gelb DJ, Oliver E, Gilman S (1999) Diagnostic criteria for Parkinson disease. Arch Neurol 56:33–39
15. Weintraub D, Hoops S, Shea JA et al (2009) Validation of the questionnaire for impulsive–compulsive disorders in Parkinson’s disease. Mov Disord 24:1461–1467
16. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington, DC
17. Movement Disorder Society Task Force on Rating Scales for Parkinson’s Disease (2013) The Unified Parkinson’s Disease Rating Scale (UPDRS): status and recommendations. Mov Disord 18:738–750
18. Goetz CG, Poewe W, Rascol O et al (2004) Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations. Mov Disord 19:1020–1028
19. Folstein MF, Folstein SE, McHugh PR (1975) “Mini Mental State”: a practical method for grading the cognitive state of patients for the clinician. J Psychiat Res 12:189–198
20. Politis M, Wu K, Loane C et al (2010) Staging of serotonergic dysfunction in Parkinson’s disease: an in vivo 11C-DASB PET study. Neurobiol Dis 40:216–221
21. Reuter M, Tisdall MD, Qureshi A, Buckner RL, van der Kouwe AJ, Fischl B (2015) Head motion during MRI acquisition reduces gray matter volume and thickness estimates. Neuroimage 107:107–115
22. Fischl B, Salat DH, van der Kouwe AJ et al (2004) Sequence-independent segmentation of magnetic resonance images. Neuroimage 23(Suppl 1):S69–S84
23. Fischl B, Salat DH, Busa E et al (2002) Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 33:341–355
24. Cardinale F, Chinnici G, Bramerio M et al (2014) Validation of FreeSurfer-estimated brain cortical thickness: comparison with histologic measurements. Neuroinformatics 12:535–542
25. Mulder ER, de Jong RA, Knol DL (2014) Hippocampal volume change measurement: quantitative assessment of the reproducibility of expert manual outlining and the automated methods FreeSurfer and FIRST. Neuroimage 92:169–181
26. Malone IB, Leung KK, Clegg S et al (2015) Accurate automatic estimation of total intracranial volume: a nuisance variable with less nuisance. Neuroimage 104:366–372
27. Robinson TE, Berridge KC (2003) Addiction. Annu Rev Psychol 54:25–53
28. Haber SN (2014) The place of dopamine in the cortico-basal ganglia circuit. Neuroscience 282:248–257
29. Berridge KC (2007) The debate over dopamine’s role in reward: the case for incentive salience. Psychopharmacology 191:391–431
30. Schultz W (2011) Potential vulnerabilities of neuronal reward, risk, and decision mechanisms to addictive drugs. Neuron 69:603–617
31. Hill SY, De Bellis MD, Keshavan MS et al (2001) Right amygdala volume in adolescent and young adult offspring from families at high risk for developing alcoholism. Biol Psychiatry 49:894–905
32. Muhlert N, Lawrence AD (2015) Brain structure correlates of emotion-based rash impulsivity. Neuroimage 115:138–146
33. Price JL (2005) Free will versus survival: brain systems that underlie intrinsic constraints on behavior. Comp Neurol 493:132–139
34. Kringelbach ML (2005) The human orbitofrontal cortex: linking reward to hedonic experience. Nat Rev Neurosci 6:691–702
35. Rushworth MF, Kolling N, Sallet J, Mars RB (2012) Valuation and decision-making in frontal cortex: one or many serial or parallel systems? Curr Opin Neurobiol 22:946–955
36. Cho SS, Pellecchia G, Aminian K et al (2013) Morphometric correlation of impulsivity in medial prefrontal cortex. Brain Topogr 26:479–487
37. Politis M, Wu K, Loane C et al (2014) Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson’s disease patients. J Clin Invest 124:1340–1349
38. Voon V, Fernagut PO, Wickens J et al (2009) Chronic dopaminergic stimulation in Parkinson’s disease: from dyskinesias to impulse control disorders. Lancet Neurol 8:1140–1149
39. Cerasa A, Messina D, Pugliese P et al (2011) Increased prefrontal volume in PD with levodopa-induced dyskinesias: a voxel-based morphometry study. Mov Disord 26:807–812
40. Cerasa A, Morelli M, Augimeri A et al (2013) Prefrontal thickening in PD with levodopa-induced dyskinesias: new evidence from cortical thickness measurement. Parkinsonism Relat Disord 19:123–125
41. Morgante F, Espay AJ, Gunraj C, Lang AE, Chen R (2006) Motor cortex plasticity in Parkinson’s disease and levodopa-induced dyskinesias. Brain 129:1059–1069
42. Cerasa A, Fasano A, Morgante F et al (2014) Maladaptive plasticity in levodopa-induced dyskinesias and tardive dyskinesias: old and new insights on the effects of dopamine receptor pharmacology. Front Neurol 9(5):49
43. Vernon AC, Modo M (2012) Do levodopa treatments modify the morphology of the parkinsonian brain? Mov Disord 27:166–167
44. Finlay CJ, Duty S, Vernon AC (2014) Brain morphometry and the neurobiology of levodopa-induced dyskinesias: current knowledge and future potential for translational pre-clinical neuroimaging studies. Front Neurol 5:95
45. Salgado-Pineda P, Delaveau P, Falcon C, Blin O (2006) Brain T1 intensity changes after levodopa administration in healthy subjects: a voxel-based morphometry study. Br J Clin Pharmacol 62:546–551
46. Kolb B, Gibb R (2015) Plasticity in the prefrontal cortex of adult rats. Front Cell Neurosci 9:15